Rheumatoid Arthritis
Conditions
Interventions
Sponsors
China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Compliance with the 2010 ACR/EULAR RA classification criteria; 2. DAS28 3.2 - 5.1; 3. RA patients who Compliance with the syndrome of spleen deficiency and dampness toxic stasis obstruction; 4. Disease course <=24 months; 5. Aged18 to 65 years old; 6. The patient was informed and agreed to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with severe organ disease or mental illness; 2. Patients who are allergic to the drugs involved in the study protocol or who have contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DAS28 remission rate;DAS28 Low activity rate;EULAR response standard; | — |
Secondary
| Measure | Time frame |
|---|---|
| CDAI remission rate;SDAI remission rate;Clinical disease activity index, CDAI;Simplified disease activity index, SDAI;Visual Analogue Scale/Score, VAS;patient's global assessment ofdisease activity, PGA;physician's global assessment of disease activity, MDGA;TCM syndrome score;SF-36;HAQ-DI;FACIT-Fatigue;Incidence rate;Sharp van der Heijde score;RA color Doppler ultrasound joint semi-quantitative score; | — |
Countries
China
Contacts
Public ContactWei Cao
China Academy of Chinese Medical Sciences
Outcome results
None listed